Products
Online Inquiry
BMS-986172
Inquiry
Cat. No.:
OB0425LY-173
Synonyms:
1808258-99-2; (2S)-4-[1-(Cyclopropylmethyl)pyrazol-3-yl]-2-[2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl]-5-(5-oxo-1H-tetrazol-4-yl)-2-(trifluoromethyl)-1,3-dihydropyridin-6-one; (6S)-4-[1-(Cyclopropylmethyl)-1H-pyrazol-3-yl]-3-(2,5-dihydro-5-oxo-1H-tetrazol-1-yl)-6-[2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl]-5,6-dihydro-6-(trifluoromethyl)-2(1H)-pyridinone; (S)-4-(1-(Cyclopropylmethyl)-1H-pyrazol-3-yl)-6-(2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl)-3-(5-oxo-4,5-dihydro-1H-tetrazol-1-yl)-6-(trifluoromethyl)-5,6-dihydropyridin-2(1H)-one
Size:
5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg
CAS No.:
1808258-99-2
Compound CID:
136970071
Specification
Description:
BMS-986172 is a selective GAT2 inhibitor mainly used to regulate the immune system.
Formula Weight:
589.47
Applications:
BMS-986172 can be used to study metabolic disorders such as obesity and NASH studies.
Storage:
Storage at 4°C.
Formula:
C24H22F7N7O3
Appearance:
Solid
Purity:
99.48%, determined by HPLC.
Solubility:
DMSO
Pathway:
Metabolic enzyme/Protease
Identity:
Confirmed by NMR and LC-MS.
Target:
Acyltransferase
Library Information
Solubility:
DMSO